The Trump administration is expected to unveil an executive action in the near future that would significantly restrict temporary (“nonimmigrant”) work visa categories. While there are multiple public data sets available from the Department of Homeland Security and the Department of State relevant to these visa categories, they are unfortunately not sufficient to answer these basic questions with great precision: How many individuals enter the country each year, for the first time, using each of these visa categories? How many individuals are already in the United States at any given moment, having previously entered using each of these visa categories?
The goal of this report is to synthesize the relevant data and clearly present what it can—and cannot—reveal about the number of individuals potentially impacted by work visa restrictions. You can read the full report here.
You can learn more about the Technology and Innovation Initiative here.
Modernizing ClinicalTrials.gov will empower patients, oncologists, and others to better understand what trials are available, where they are available, and their up-to-date eligibility criteria, using standardized search categories to make them more easily discoverable.
The current lack of public trust in AI risks inhibiting innovation and adoption of AI systems, meaning new methods will not be discovered and new benefits won’t be felt. A failure to uphold high standards in the technology we deploy will also place our nation at a strategic disadvantage compared to our competitors.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
A shift toward more circular, transparent systems would not only reduce waste and increase efficiency, but also unlock new business models, strengthen supply chain resilience, and give consumers better, more reliable information about the products they choose.